Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Type 2 Diabetes - Faecalibacterium prausnitzii |
📓
Could dysbiosis of inflammatory and anti-inflammatory gut bacteria have an implications in the development of type 2 diabetes? A pilot investigation. BMC research notes (BMC Res Notes ) Vol: 14 Issue 1 Pages: 52 Pub: 2021 Feb 6 Epub: 2021 Feb 6 Authors Kulkarni P , Devkumar P , Chattopadhyay I , Html Article Publication |
Type 2 Diabetes - Faecalibacterium prausnitzii |
📓
The importance of Faecalibacterium prausnitzii in human health and diseases. New microbes and new infections (New Microbes New Infect ) Vol: 43 Issue Pages: 100928 Pub: 2021 Sep Epub: 2021 Jul 24 Authors Parsaei M , Sarafraz N , Moaddab SY , Ebrahimzadeh Leylabadlo H , Publication |
Type 2 Diabetes - Faecalibacterium prausnitzii |
📓
[The characteristics of gut microbiota in type 2 diabetes mellitus patients with hypertriglyceridemia]. Zhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi ) Vol: 102 Issue 47 Pages: 3763-3768 Pub: 2022 Dec 20 Epub: Authors Zhang Q , Hu WM , Deng YL , Long Q , Jin P , Publication |
Type 2 Diabetes - Faecalibacterium prausnitzii |
📓
Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene (Gene ) Vol: 537 Issue 1 Pages: 85-92 Pub: 2014 Mar 1 Epub: 2013 Dec 8 Authors Remely M , Aumueller E , Merold C , Dworzak S , Hippe B , Zanner J , Pointner A , Brath H , Haslberger AG , Publication |
Type 2 Diabetes - Faecalibacterium prausnitzii |
📓
The association of type II diabetes with gut microbiota composition. Microbial pathogenesis (Microb Pathog ) Vol: 110 Issue Pages: 630-636 Pub: 2017 Sep Epub: 2017 Jul 21 Authors Navab-Moghadam F , Sedighi M , Khamseh ME , Alaei-Shahmiri F , Talebi M , Razavi S , Amirmozafari N , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.